Hosted on MSN10m
Wegovy sales double to boost Novo Nordisk's fourth quarter but slower growth predictedLONDON/COPENHAGEN (Reuters) -Obesity drug maker Novo Nordisk forecast slower growth this year after ... U.S. rival Eli Lilly last month forecast fourth-quarter sales of weight-loss drug Zepbound below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback